Nexalin Technology NXL
NASDAQ NXL
$5.73 -1.82 (-24.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026)

Updated

Nexalin Technology's Cash & Equivalents came in at $1 million for Q2 2026, up 133.0% from $431,320 a year earlier but down 16.8% from the prior quarter.

Analysis

Nexalin Technology (NXL) Cash & Equivalents (2021 - 2026) Analysis & Trends

At the end of FY2025, Nexalin Technology's Cash & Equivalents was $654,783, up 14.0% from FY2024.

  • Cash & Equivalents carries a four-year compound annual growth rate of -0.3% (FY2021 to FY2025).
  • Going back by year, Cash & Equivalents was $574,485 in FY2024 (-1.0%), $580,230 in FY2023 (+256.5%), $162,743 in FY2022 (-75.4%) and $661,778 in FY2021.
  • The five-year range for quarterly Cash & Equivalents is $81,421 (Q3 2024) to $7.86 million (Q3 2022).
  • Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 94.0% over the last eight quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2025 (growth of 624.7%), and the weakest in Q3 2023 (a decline of 95.4%).
  • Business Quant data shows NXL's Cash & Equivalents at $1.21 million (Q1 2026), $654,783 (Q4 2025) and $590,075 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 5.10 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 2.76 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 1.69 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 3.39 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 2.91 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 708.00 Mn
10 Nexalin Technology 4.20 Mn -7.59 Mn 8,897.00 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.21 Mn
Dec 31, 2025 654,783.00
Sep 30, 2025 590,075.00
Jun 30, 2025 431,320.00
Mar 31, 2025 622,029.00
Dec 31, 2024 574,485.00
Sep 30, 2024 81,421.00
Jun 30, 2024 848,796.00
Mar 31, 2024 546,255.00
Dec 31, 2023 580,230.00
Sep 30, 2023 361,397.00
Jun 30, 2023 231,722.00
Mar 31, 2023 174,961.00
Dec 31, 2022 162,743.00
Sep 30, 2022 7.86 Mn
Dec 31, 2021 661,778.00
API Access

Nexalin Technology Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXL&period=max&api_key=YOUR_API_KEY